Bradykinin (BK) has been proven to promote development and migration of head and neck squamous cell carcinoma (HNSCC) cells via epidermal development factor receptor (EGFR) transactivation. of COX-2 was inhibited with the EGFR kinase inhibitor gefitinib or mitogen turned on proteins kinase kinases (MEK) inhibitors (PD98059 or U0126). These outcomes claim that EGFR and MAPK… Continue reading Bradykinin (BK) has been proven to promote development and migration of